Gianluca De Rubeis: A Safer Approach to Antiplatelet Timing in Endovascular Aneurysm Treatment
Gianluca De Rubeis, Interventional Neuroradiologist at San Camillo Forlanini Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Neuroradiology, adding:
”’The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms’ — our systematic review is now live.
Here’s the key takeaway: antiplatelet therapy — given to reduce thromboembolic complications — doesn’t need to be administered at the very start of the procedure.
It can be safely delayed until after the first coil is deployed, with no difference in outcomes.
Why does this matter?
Once the first coil is in place, the aneurysm is protected.
Giving antiplatelet therapy at that point keeps the same efficacy against clot complications — while making the overall procedure safer.
A simple but important shift in how we think about timing in the most critical moments of endovascular treatment.
Proud of this work and the incredible team behind it.”
Title: The timing of intraprocedural antiplatelet therapy did not affect outcomes in endovascular treatment of ruptured intracranial aneurysms: A systematic review
Authors: Gianluca De Rubeis, Sebastiano Fabiano, Luca Bertaccini, Alberto Vito Terrana, Riccardo Ricciuti, Luca Saba, Enrico Pampana
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge